软云科技 RYET 深 沪
已收盘 11-13 16:00:00 美东时间
0.5089
-0.001
-0.29%
华盛通- 最 高0.5475
- 今 开0.46
- 成交量 7297股
- 最 低 0.46
- 昨 收 0.5104
- 总市值 1897.18万
- 52周最高 2.03
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 0.46
- 委 比 -3.09%
- 总股本 3728.00万
- 历史最高 21.00
- 量 比 0.81
- 振 幅 17.14%
- 历史最低 0.46
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RYET Launches Co-Funded AI Script and Film Production Program on YeeZo
Ruanyun Edai Technology Inc. (RYET) and its co-investor have committed RMB 2 million to develop approximately 400 AI-assisted scripts and 30 AI films over 12 months. The project, using RYET's YeeZo platform, aims to produce and distribute content internationally through Formind Global, with profits shared 60% to RYET and 40% to the co-investor. The initiative reflects confidence in YeeZo's production model and targets growing demand for short-for...
11-11 14:00
软云科技收涨3.23%，成交额7858美元
11月10日，软云科技（RYET）收涨3.23%，报0.54美元，成交额7858美元，市值2011.63万美元。 行情数据 • 开盘价：0.6美元 • 最高价...
11-10 08:53
BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific
BioNexus Gene Lab Corp. introduces BGLC 1Lab, a laboratory workflow product designed to connect clinic orders, specimen reception, bench activity, scientific review, and report delivery in one traceable record. The product features secure reporting, private AI Q&A, and agentic AI workflows under laboratory control. BioNexus plans to integrate Ruanyun's CogniAI platform for document processing. The pilot focuses on GeneMatrix analysis and workflow...
11-03 14:00
软云科技收跌2.63%，成交额1965美元
11月3日，软云科技（RYET）收跌2.63%，报0.68美元，成交额1965美元，市值2537.28万美元。 行情数据 • 开盘价：0.67美元 • 最高价...
11-03 08:40
软云科技收跌4.49%，成交额5211美元
10月27日，软云科技（RYET）收跌4.49%，报0.67美元，成交额5211美元，市值2495.17万美元。 行情数据 • 开盘价：0.65美元 • 最高价...
10-27 07:43
软云科技收跌4.73%，成交额8903美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:43
Ruanyun Edai Technology Receives Nasdaq Noncompliance Notice
Ruanyun Edai Technology Inc. (NASDAQ:RYET) (the "Company") today announced that it received a written notice dated October 7, 2026 from Nasdaq stating that the closing bid price of its ordinary shares was below $1.00 per share for 30 consecutive business days, from August 25 through October 6, 2026....
10-10 05:22
Ruanyun Edai Technology Inks Agreement To Grant License To BioNexus Gene Lab For Its Cogni AI Document-Intelligence Platform For Healthcare In Malaysia
Ruanyun Edai Technology Inc. (NASDAQ: RYET) ("RYET" or the "Company") today announced that it has signed a definitive agreement under which, on closing, RYET would grant BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BGLC") an exclusive license of its Cogni AI document-intelligence platform for healthcare ...
10-05 21:02
RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
RYET has signed a definitive agreement with BGLC to grant an exclusive 20-year license for its Cogni AI platform in Malaysia's healthcare sector, receiving a 10% royalty on qualifying technology receipts and 560,000 BGLC shares. The partnership aligns with Malaysia's push to digitize its public healthcare system, with RYET's Formind Group strategy aiming to expand AI into new industries and markets. BGLC will lead local implementation, while RYET...
10-05 13:00
Ruanyun Edai Technology Expects FY27 H1 Revenue Range ~$9.3M - $9.5M; FY26 H1 Revenue Expected In Range Of ~$8.M - $9.1M
Ruanyun Edai Technology Inc. (NASDAQ:RYET) ("Ruanyun" or the "Company") today announced that it expects preliminary unaudited revenue in the range of approximately US$9.3 million to US$9.5 million (RMB63.0 million to RMB64.5 million) for the six months ended September 30, 2026, the first half of its...
10-02 20:35
